CHP-UN.TO - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 25/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.8x).

Beta (Market Relation)

0.76x

Defensive

Volatility (5Y p.a.)

16.7% p.a.

5-Year Horizon

Max Drawdown (5Y)

-25.3%

5-Year Horizon

Sharpe Ratio

-0.15

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+3%
3 Years	16.5%	-15.6%	0.17	+5.3%
5 Years	16.7%	-25.3%	-0.15	+0.1%
10 Years	17.7%	-29.1%	-0.09	+0.8%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 316%.

Unprofitable business model: The company is currently generating net losses.

Strong cyclicality: The business model is sensitive to economic downturns.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

5 ISS Score: 5 / 10

Audit Risk

7 ISS Score: 7 / 10

Board Risk

6 ISS Score: 6 / 10

Short Ratio

23.34